ENVALITH
株式会社エラン logo

ELAN Corporation

6099Prime MarketServices

株式会社エラン logo
ELAN Corporation6099

Business

Eran Corporation is a company that provides the "CS Set," a combination of rental clothing and towels with laundry service and provision of daily necessities, to hospital inpatients and residents of nursing care health facilities, special elderly nursing homes, and similar facilities. Founded in 1995, the company listed on the Tokyo Stock Exchange Mothers market in 2014 and transitioned to the Prime Market in 2022. In October 2024, M3, Inc. became its parent company. Through a nationwide network of 30 branch offices and sales offices, the service has been introduced at 2,830 facilities (as of the end of December 2025). The daily-rate pricing system provides users with the convenience of being able to be hospitalized or admitted to a facility "empty-handed," building a win-win ecosystem that includes hospitals, facilities, and linen supply operators.

Business Model

Eran introduces the CS Set (Care Support Set) to hospitals and nursing care facilities, collecting usage fees from users on a daily-rate basis according to the number of days of hospitalization or admission. Laundering of clothing and towels is outsourced to linen supply vendors, while daily necessities are supplied via distributors. The company pays outsourcing commissions to facilities, while maintaining a stock-type revenue structure in which sales accumulate as the number of users increases. Net increases in the number of facilities where the service is introduced (an increase of 260 facilities in the current period) are the primary driver of sales growth.

Company Strengths

Revenue grew from ¥31,636 million in FY2021 to ¥55,449 million in FY2025, achieving five consecutive periods of revenue growth. In the current period, 359 new facilities were acquired against only 99 cancellations, resulting in a net increase of 260 facilities and a cumulative total of 2,830 introduced facilities. This accumulation of facilities forms the foundation for stock-type recurring revenue.

As of the end of December 2025, the company operates 30 branches and sales offices nationwide. In the current period, a new Kobe branch was established to cover the western Kinki region. On the logistics side, the Kansai Logistics Hanshin TC was also established, reflecting planned nationwide network development in both sales and logistics.

In October 2024, M3, Inc. became the parent company, enabling the use of the group's IT and DX expertise to improve operational efficiency and strengthen sales capabilities. The SG&A ratio for the current period declined by 1.3 percentage points year-on-year to 13.7%, reflecting the effects of improved cost management.

ENVALITH's Perspective

Q1 FY2026 operating profit of ¥1,441 million (up 21.9% year-on-year) represents progress of 28.8% against the full-year forecast of ¥5,000 million, indicating a favorable trend. Gross profit margin improved to 23.0% (up from 22.3% in the same period last year), with the leveling effect of capitalizing the Original Patient Wear "lifte" as a tangible fixed asset contributing to margin improvement. There has been no revision to the full-year earnings forecast, and the situation appears to be one of exploring potential upside.

Total non-operating expenses in Q1 FY2026 rose sharply to ¥77 million (versus ¥20 million in the same period last year). The main factors were a foreign exchange loss of ¥14 million and an equity-method investment loss of ¥40 million (versus zero in the same period last year). As overseas expansion accelerates in earnest, the recording of losses at equity-method affiliates warrants continued monitoring, and foreign exchange volatility as an external factor also represents a structural risk affecting recurring profit.

The allowance for doubtful accounts (current) at the end of Q1 FY2026 increased to ¥953 million, up from ¥882 million at the end of the previous fiscal year. Accounts receivable and contract assets expanded to ¥7,310 million (from ¥7,027 million at the previous fiscal year-end), and the associated expansion of receivable balances alongside revenue growth, along with collection risk, continues to warrant close attention. Given the nature of receivables from medical and nursing care facilities, regulatory system changes or deterioration in facility management could increase the risk of bad debt.

Growth Strategy

Pursuing mid-to-long-term growth along four axes: domestic facility expansion, price pass-through, DX promotion, and overseas expansion

Leveraging a nationwide sales network of 30 locations, the company continues to acquire new contracts with hospitals and nursing care facilities. In 1Q FY2026, 70 new facilities were added against 44 cancellations, resulting in a net increase of 26 facilities, bringing the cumulative number of facilities to 2,856 at quarter-end. Against the backdrop of market expansion driven by an aging population, the company aims to expand recurring revenue by accumulating facility numbers.

Previously, the Original Patient Wear "lifte" was recorded as "supplies" and expensed in full at the time of issuance. From 1Q FY2026, it has been capitalized as a tangible fixed asset and depreciated on a straight-line basis over three years. The resulting smoothing of costs has become evident in improved gross profit margin, with the 1Q FY2026 gross profit margin improving to 23.0% (from 22.3% in the same period of the previous year).

The company continues to promote DX and strengthen sales capabilities by leveraging the M3 Group's healthcare IT infrastructure. Through digitalization and efficiency improvements in facility-oriented services, the company aims to enhance competitiveness both in deepening relationships with existing facilities and in developing new ones.

Overseas expansion has begun in earnest with the consolidation of two Vietnamese subsidiaries. However, in 1Q FY2026, an investment loss of ¥40 million was recorded under the equity method, and building a business foundation for profitability remains a challenge. Foreign exchange fluctuation risk also requires close monitoring as a factor affecting ordinary profit.

Last updated: July 17, 2026